The glycemic effects of continuous glucose monitoring (CGM) in adults with type 2 diabetes mellitus (T2DM) have been studied extensively, but how CGM information is translated into clinical or self-management action remains less understood. We mapped these processes and implementation conditions across ambulatory...
Objective Hypoglycemia is common in patients with adrenal insufficiency (AI), who require lifelong glucocorticoid replacement therapy. However, whether this therapy restores physiological glycemic fluctuations in patients with AI remains unclear. This study aimed to characterize glucose fluctuation pattern in patients...
C. Ning, Rui Zhang, Wei Liu et al.· Endocrine Connections· 0 citations
Teprotumumab N01 treatment was associated with a substantial, early, and broadly reversible increase in circulating IGF-1 in patients with moderate-to-severe TED, but IGF-1 dynamics did not serve as an independent indicator of glycemic deterioration.
Wei Zhao, Lingli Zhou, Ying Gao et al.· Frontiers in Endocrinology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.